You are here: Home » News-CM » Companies » Results
Business Standard

Brawn Biotech standalone net profit declines 84.62% in the December 2019 quarter

Capital Market 

Sales decline 37.73% to Rs 13.22 crore

Net profit of Brawn Biotech declined 84.62% to Rs 0.04 crore in the quarter ended December 2019 as against Rs 0.26 crore during the previous quarter ended December 2018. Sales declined 37.73% to Rs 13.22 crore in the quarter ended December 2019 as against Rs 21.23 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales13.2221.23 -38 OPM %0.451.84 -PBDT0.070.37 -81 PBT0.060.36 -83 NP0.040.26 -85

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 11 2020. 17:32 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU